Lenz climbs on quarterly revenue beat
12/08/2026 12:41
BUZZ-Lenz climbs on quarterly revenue beat ** Shares of eye drop maker Lenz Therapeutics LENZ.O rise 7.7% to $5.61 premarket
** Co's Q2 revenue of $5.5 million beats analysts' average expectation of $2.4 million, helped by strong sales of its eye drop Vizz
** Vizz is used to treat age-related blurry near vision, or presbyopia, in adults
** Co reports Q2 loss of $1.02/shr vs analysts' average loss estimate of $1.07/shr, according to LSEG data
** Up to last close, stock down 67.4% YTD
(Reporting by Christy Santhosh)